TWINRIX
NDC 58160-815, Hepatitis A and Hepatitis B (Recombinant) Vaccine, injection, suspension, from GlaxoSmithKline Biologicals SA.
- Product NDC
- 58160-815
- Status
- Listed
- Labeler
- GlaxoSmithKline Biologicals SA
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA103850
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58160-815 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)720 [iU]/mL
- HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN20 ug/mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Hepatitis A Vaccines [CS]; Inactivated Hepatitis A Virus Vaccine [EPC]; Vaccines, Inactivated [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58160-815-52 | 58160081552 | 10 SYRINGE in 1 CARTON (58160-815-52) / 1 mL in 1 SYRINGE (58160-815-43) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58160-815 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58160-815 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58160-815. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.